Hydrangea dulcis folium preserves beta-cell mass in diabetic db/db mice

Area of Science:

• Pharmacology
• Metabolic Diseases
• Natural Product Research

Background:

• Type 2 diabetes is characterized by hyperglycemia and impaired insulin secretion.
• db/db mice are a widely used genetic model for studying type 2 diabetes.
• Hydrangea dulcis folium (HDF) is a plant with potential medicinal properties.

Purpose of the Study:

• To investigate the anti-diabetic effects of Hydrangea dulcis folium (HDF) in a mouse model.
• To determine the impact of HDF on glucose levels, insulin secretion, and related metabolic parameters.
• To evaluate the dose-dependent efficacy of HDF.

Main Methods:

• Administration of HDF (1% and 3% concentrations) to db/db mice and their littermates (db/-).
• Monitoring of blood glucose and insulin levels.
• Assessment of beta-cell mass, food intake, body weight, and blood lipid profiles.

Main Results:

• HDF supplementation significantly decreased glucose levels and increased insulin levels in a dose-dependent manner.
• HDF treatment ameliorated hyperglycemia and improved glucose homeostasis by preserving beta-cell mass and enhancing insulin secretion.
• The 3% HDF dose notably reduced food intake, weight gain, and blood lipids in db/db mice.

Conclusions:

• Hydrangea dulcis folium demonstrates significant anti-diabetic efficacy in db/db mice.
• HDF improves glucose homeostasis and insulin secretion, potentially by protecting beta-cell mass.
• HDF shows promise as a natural therapeutic agent for managing type 2 diabetes and associated metabolic disturbances.